Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.12, issue.5, pp.1157-67, 2012. ,
Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation, J Am Soc Nephrol JASN, vol.21, issue.8, pp.1398-406, 2010. ,
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.33, issue.12, pp.1288-94, 2014. ,
De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.13, issue.6, pp.1541-1549, 2013. ,
De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.2, pp.312-321, 2011. ,
Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities, Transplantation, vol.75, issue.1, pp.43-52, 2003. ,
HLA antibody specification using single-antigen beads--a technical solution for the prozone effect, Transplantation, vol.92, issue.5, pp.510-515, 2011. ,
Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays, Transplantation, vol.98, issue.6, pp.625-656, 2014. ,
Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays. HLA, vol.91, pp.507-520, 2018. ,
Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.5, pp.1063-71, 2009. ,
Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection, J Am Soc Nephrol JASN, vol.29, issue.2, pp.606-625, 2018. ,
Summary of FDA antibody-mediated rejection workshop, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.5, pp.896-906, 2011. ,
The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis, Transplantation, vol.102, issue.4, pp.557-68, 2018. ,
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.5, pp.1099-107, 2009. ,
Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection, Transplantation, vol.75, issue.9, pp.1490-1495, 2003. ,
Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation, Hum Immunol, vol.66, issue.4, pp.350-358, 2005. ,
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.1, pp.117-138, 2007. ,
C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption, J Am Soc Nephrol JASN, vol.12, issue.11, pp.2482-2491, 2001. ,
Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.10, issue.9, pp.2033-2075, 2010. ,
A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.6, issue.2, pp.346-51, 2006. ,
Desensitization in kidney transplantation: review and future perspectives, Clin Transplant, vol.28, issue.4, pp.494-507, 2014. ,
Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies, Blood Purif, vol.40, issue.2, pp.167-72, 2015. ,
Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, 2018. ,
Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay, Transplantation, vol.101, issue.3, pp.624-654, 2017. ,
Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation, Transplantation, vol.102, issue.6, pp.257-64, 2018. ,
Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin, Hum Immunol, vol.66, issue.4, pp.364-70, 2005. ,
Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.34, issue.6, pp.863-868, 2015. ,
Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Transfusion (Paris), vol.55, pp.727-762, 2015. ,
Efficacy and safety of plasma exchange: ann 11-year single-center experience of 2730 procedures in 317 patients, Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis, vol.51, issue.2, pp.209-223, 2014. ,
Immunoadsorption, current status and future developments, Expert Opin Investig Drugs, vol.9, issue.9, pp.2017-2055, 2000. ,
Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy, Transpl Int Off J Eur Soc Organ Transplant, vol.25, issue.5, pp.506-523, 2012. ,
,
,
, Acta Haematol, vol.20, issue.1-4, pp.156-66, 1958.
The HLA system. First of two parts, N Engl J Med, vol.343, issue.10, pp.702-711, 2000. ,
Biologic mechanisms and clinical consequences of pregnancy alloimmunization, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.5, pp.1059-67, 2018. ,
Incidence and risk factors of anti-HLA immunization after pregnancy, Hum Immunol, vol.74, issue.8, pp.946-51, 2013. ,
Frequency and determinants of pregnancy-induced child-specific sensitization, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.13, issue.3, pp.746-53, 2013. ,
Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child, Hum Immunol, vol.63, issue.6, pp.452-460, 2002. ,
The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion (Paris), vol.49, pp.1825-1860, 2009. ,
Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized, Blood, vol.58, issue.5, pp.1007-1018, 1981. ,
Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients, Transplantation, vol.32, issue.3, pp.177-83, 1981. ,
Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects, Transplantation, vol.44, issue.1, pp.123-132, 1987. ,
Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody, Blood, vol.68, issue.3, pp.627-659, 1986. ,
Leukocyte reduction of blood components: public policy and new technology, Transfus Med Rev, vol.14, issue.1, pp.34-52, 2000. ,
Increased antibody responsiveness to blood transfusions in pediatric patients, Transplantation, vol.58, issue.12, pp.1361-1366, 1994. ,
Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates, J Am Soc Nephrol JASN, vol.15, issue.3, pp.818-842, 2004. ,
Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion (Paris), vol.50, pp.1328-1362, 2010. ,
Alloantibody responses in multiply transfused sickle cell patients, Tissue Antigens, vol.30, issue.4, pp.161-167, 1987. ,
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.12, issue.5, pp.1157-67, 2012. ,
Incidence and impact of de novo donor-specific alloantibody in primary renal allografts, Transplantation, vol.95, issue.3, pp.410-417, 2013. ,
De novo donor HLAspecific antibodies after heart transplantation are an independent predictor of poor patient survival, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.2, pp.312-321, 2011. ,
De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.33, issue.12, pp.1273-81, 2014. ,
De novo donorspecific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.33, issue.12, pp.1288-94, 2014. ,
Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.14, issue.4, pp.867-75, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01915082
De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.13, issue.6, pp.1541-1549, 2013. ,
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.12, issue.2, pp.388-99, 2012. ,
Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy, Clin J Am Soc Nephrol CJASN, vol.7, issue.8, pp.1310-1319, 2012. ,
Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure, Transplantation, vol.94, issue.7, pp.738-781, 2012. ,
Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation, J Am Soc Nephrol JASN, vol.21, issue.8, pp.1398-406, 2010. ,
C4d fixing, luminex binding antibodies -a new tool for prediction of graft failure after heart transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.12, pp.2809-2824, 2007. ,
Significance of the positive crossmatch test in kidney transplantation, N Engl J Med, vol.280, issue.14, pp.735-744, 1969. ,
The Banff 97 working classification of renal allograft pathology, Kidney Int, vol.55, issue.2, pp.713-736, 1999. ,
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.2, pp.293-307, 2018. ,
The importance of non-HLA antibodies in transplantation, Nat Rev Nephrol, vol.12, issue.8, pp.484-95, 2016. ,
Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens, J Am Soc Nephrol JASN, 201908. ,
International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.32, issue.12, pp.1147-62, 2013. ,
Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.35, issue.4, pp.397-406, 2016. ,
Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.9, pp.1792-802, 2011. ,
, , 2016.
, Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.16, issue.10, pp.2816-2851, 2016.
Antibody-Mediated Rejection of Solid-Organ Allografts, N Engl J Med, vol.379, issue.12, pp.1150-60, 201820. ,
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donorspecific antibodies, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.11, pp.2561-70, 2009. ,
The impact of donor-specific anti-HLA antibodies on late kidney allograft failure, Nat Rev Nephrol, vol.8, issue.6, pp.348-57, 2012. ,
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection, Transplant Rev Orlando Fla, vol.23, issue.3, pp.139-50, 2009. ,
Diagnostic challenges in chronic antibody-mediated rejection, Nat Rev Nephrol, vol.8, issue.5, pp.255-262, 2012. ,
Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.10, issue.3, pp.510-517, 2010. ,
Review: The transcripts associated with organ allograft rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.4, pp.785-95, 2018. ,
Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation, Kidney Int, vol.95, issue.1, pp.188-98, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-01964955
Effect of antibodies on endothelium, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.11, pp.2459-65, 2009. ,
HLA antibody identification with single antigen beads compared to conventional methods, Hum Immunol, vol.66, issue.9, pp.989-97, 2005. ,
Detection of donor-specific antibodies in kidney transplantation, vol.110, 2014. ,
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.10, issue.3, pp.582-591, 2010. ,
Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure, Transplantation, vol.99, issue.6, pp.1156-64, 2015. ,
Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay, Transplantation, vol.101, issue.3, pp.624-654, 2017. ,
Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.15, issue.11, pp.2921-2951, 2015. ,
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.9, pp.1868-76, 2011. ,
The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.4, pp.1027-1058, 2007. ,
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.5, pp.1099-107, 2009. ,
Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays, Transplantation, vol.98, issue.6, pp.625-656, 2014. ,
Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays. HLA, vol.91, pp.507-520, 2018. ,
HLA antibody specification using single-antigen beads--a technical solution for the prozone effect, Transplantation, vol.92, issue.5, pp.510-515, 2011. ,
Positive virtual crossmatch with negative flow crossmatch results in two cases, Transpl Immunol, vol.25, issue.1, pp.77-81, 2011. ,
Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation, Clin Transplant, vol.29, issue.5, pp.393-402, 2015. ,
Deciphering allogeneic antibody response against native and denatured HLA epitopes in organ transplantation, Eur J Immunol, vol.45, issue.7, pp.2111-2132, 2015. ,
Calibration free concentration analysis by surface plasmon resonance in a capture mode, Talanta, vol.148, pp.478-85, 2016. ,
Overcoming nonspecific binding to measure the active concentration and kinetics of serum anti-HLA antibodies by surface plasmon resonance, Biosens Bioelectron, vol.117, pp.191-200, 2018. ,
Measuring anti-HLA antibody active concentration and affinity by surface plasmon resonance: Comparison with the luminex single antigen flow beads and T-cell flow cytometry crossmatch results, Mol Immunol, vol.108, pp.34-44, 2019. ,
Complement-binding anti-HLA antibodies and kidney-allograft survival, N Engl J Med, vol.369, issue.13, pp.1215-1241, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02325503
Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients, Transpl Int Off J Eur Soc Organ Transplant, vol.22, issue.10, pp.982-991, 2009. ,
Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss, J Am Soc Nephrol JASN, vol.26, issue.2, pp.457-67, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01910934
C1q Binding Activity of De Novo Donorspecific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection, Transplantation, vol.99, issue.6, pp.1151-1156, 2015. ,
Clinical Utility of Complement Dependent Assays in Kidney Transplantation, Transplantation, vol.102, issue.1S, pp.14-22, 2018. ,
Understanding solid-phase HLA antibody assays and the value of MFI, Hum Immunol, vol.78, issue.7-8, pp.471-80, 2017. ,
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.15, issue.4, pp.1003-1016, 2015. ,
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury, J Am Soc Nephrol JASN, vol.27, issue.1, pp.293-304, 2016. ,
IgM antibodies in renal transplantation, Clin Transplant, vol.11, issue.6, pp.558-64, 1997. ,
IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype, Clin Transplant, vol.15, issue.6, pp.28-35, 2001. ,
Flow cytometrydetected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome, Transplantation, vol.68, issue.12, pp.1855-1863, 1999. ,
Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients, Hum Immunol, vol.70, issue.8, pp.600-604, 2009. ,
Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study, Clin Transpl, vol.32, pp.173-182, 2016. ,
The role of IgA anti-HLA class I antibodies in kidney transplant survival, Transplantation, vol.56, issue.1, pp.207-218, 1993. ,
Correlation of ELISAdetected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection, Transplantation, vol.62, issue.2, pp.201-206, 1996. ,
Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival, Int J Immunogenet, vol.45, issue.3, pp.95-101, 2018. ,
Summary of FDA antibody-mediated rejection workshop, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.5, pp.896-906, 2011. ,
The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis, Transplantation, vol.102, issue.4, pp.557-68, 2018. ,
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.1, pp.117-138, 2007. ,
C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption, J Am Soc Nephrol JASN, vol.12, issue.11, pp.2482-2491, 2001. ,
Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection, J Am Soc Nephrol JASN, vol.29, issue.2, pp.606-625, 2018. ,
Reducing de novo donorspecific antibody levels during acute rejection diminishes renal allograft loss, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.5, pp.1063-71, 2009. ,
Complementbinding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection, Kidney Int, vol.94, issue.4, pp.773-87, 2018. ,
Desensitization: Overcoming the Immunologic Barriers to Transplantation, J Immunol Res, p.6804678, 2017. ,
Desensitization in kidney transplantation: review and future perspectives, Clin Transplant, vol.28, issue.4, pp.494-507, 2014. ,
Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.10, issue.9, pp.2033-2075, 2010. ,
Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates, Exp Clin Transplant Off J Middle East Soc Organ Transplant, vol.13, issue.1, pp.201-207, 2015. ,
Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy, Transpl Int Off J Eur Soc Organ Transplant, vol.25, issue.5, pp.506-523, 2012. ,
Quantifying the risk of incompatible kidney transplantation: a multicenter study, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.14, issue.7, pp.1573-80, 2014. ,
Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch, Transplantation, vol.92, issue.8, pp.900-906, 2011. ,
The strength of donor-specific antibody is a more reliable predictor of antibody-mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients, Clin Transplant, vol.25, issue.1, pp.96-102, 2011. ,
Factors Predicting Risk for Antibodymediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization, Transplantation, vol.99, issue.7, pp.1423-1453, 2015. ,
Present techniques for antibody removal. Transplantation, vol.84, pp.27-29, 2007. ,
Conventional apheresis therapies: a review, J Clin Apheresis, vol.26, issue.5, pp.230-238, 2011. ,
Therapeutic plasma exchange: a technical and operational review, J Clin Apheresis, vol.28, issue.1, pp.3-10, 2013. ,
The mechanisms of action of plasma exchange, Br J Haematol, vol.164, issue.3, pp.342-51, 2014. ,
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med, vol.325, issue.6, pp.393-400, 1991. ,
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue, J Clin Apheresis, vol.31, issue.3, pp.149-62, 2016. ,
Immunoadsorption, current status and future developments, Expert Opin Investig Drugs, vol.9, issue.9, pp.2017-2055, 2000. ,
Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease, Ther Apher Off J Int Soc Apher Jpn Soc Apher, vol.3, issue.3, pp.240-245, 1999. ,
Peptide based adsorbers for therapeutic immunoadsorption, Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther, vol.7, issue.1, pp.91-98, 2003. ,
Principles of separation: indications and therapeutic targets for plasma exchange, Clin J Am Soc Nephrol CJASN, vol.9, issue.1, pp.181-90, 2014. ,
Technical basis for immunoadsorption, EDTNA-ERCA J, vol.26, issue.3, pp.20-26, 2000. ,
Therapeutic protein A immunoadsorption. A review, Transfus Sci, vol.11, issue.3, pp.281-302, 1990. ,
Plasma exchange with a rotating filter, Kidney Int, vol.38, issue.1, pp.160-166, 1990. ,
Technical and clinical experience with protein A immunoadsorption columns, Transfus Sci, vol.15, issue.4, pp.419-441, 1994. ,
Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity. Atheroscler Suppl, vol.10, pp.114-135, 2009. ,
A simple and accurate method for prescribing plasma exchange, ASAIO Trans, vol.36, issue.3, pp.597-599, 1990. ,
Extracorporeal removal of anti-HLA antibodies in transplant candidates, Am J Kidney Dis Off J Natl Kidney Found, vol.16, issue.5, pp.423-454, 1990. ,
Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies, Blood Purif, vol.40, issue.2, pp.167-72, 2015. ,
Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation, Transplantation, vol.102, issue.6, pp.257-64, 2018. ,
Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.34, issue.6, pp.863-868, 2015. ,
Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Transfusion (Paris), vol.55, pp.727-762, 2015. ,
Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin, Hum Immunol, vol.66, issue.4, pp.364-70, 2005. ,
Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, 2018. ,
Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures, J Clin Apheresis, vol.22, issue.5, pp.270-276, 2007. ,
Efficacy and safety of plasma exchange: ann 11-year single-center experience of 2730 procedures in 317 patients, Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis, vol.51, issue.2, pp.209-223, 2014. ,
Complications of apheresis, Semin Dial, vol.25, issue.2, pp.152-160, 2012. ,